Aarti Pharmalabs Ltd.

Revenue reduced marginally to stand at Rs. 3581.40 millions during the quarter ended June 2023. The figure stood at Rs. 3731.50 millions during the year-ago period.Profit for the quarter ended June 2023 increased merely by0.80% to Rs. 476.30  millions from Rs. 472.50 millions.OP of the company witnessed a marginal growth to 816.00 millions from 787.10 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202306	202206	% Var	202306	202206	% Var	202303	202203	% Var
Sales	3581.40	3731.50	-4.02	3581.40	3731.50	-4.02	15112.50	9410.20	60.60
Other Income	48.60	0.00	0.00	48.60	0.00	0.00	12.80	25.10	-49.00
PBIDT	816.00	787.10	3.67	816.00	787.10	3.67	3096.20	1822.90	69.85
Interest	40.30	40.50	-0.49	40.30	40.50	-0.49	204.90	113.40	80.69
PBDT	775.70	746.60	3.90	775.70	746.60	3.90	2891.30	1709.50	69.13
Depreciation	154.40	124.10	24.42	154.40	124.10	24.42	557.70	372.30	49.80
PBT	621.30	622.50	-0.19	621.30	622.50	-0.19	2333.60	1337.20	74.51
TAX	145.00	150.00	-3.33	145.00	150.00	-3.33	616.30	270.00	128.26
Deferred Tax	35.00	22.50	55.56	35.00	22.50	55.56	95.00	45.00	111.11
PAT	476.30	472.50	0.80	476.30	472.50	0.80	1717.30	1067.20	60.92
Equity	453.10	453.10	0.00	453.10	453.10	0.00	453.10	455.60	-0.55
PBIDTM(%)	22.78	21.09	8.02	22.78	21.09	8.02	20.49	19.37	5.76